Published in Immunity on June 01, 1999
CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med (2007) 4.66
The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med (2001) 3.63
IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest (2000) 3.19
Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity (2008) 2.09
Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection. J Exp Med (2001) 1.57
IFNγ/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children. PLoS Pathog (2014) 1.17
Short-lived IFN-γ effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity. PLoS Pathog (2011) 1.15
Natural regulatory T cells in malaria: host or parasite allies? PLoS Pathog (2010) 1.15
Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells. Proc Natl Acad Sci U S A (2000) 1.13
Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells. AIDS Res Hum Retroviruses (2004) 1.10
Identification of protective Lassa virus epitopes that are restricted by HLA-A2. J Virol (2006) 1.07
Role of endogenous and induced regulatory T cells during infections. J Clin Immunol (2008) 1.03
Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria. Infect Immun (2002) 1.02
Antagonists and non-toxic variants of the dominant wheat gliadin T cell epitope in coeliac disease. Gut (2005) 0.94
Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations. J Clin Invest (2002) 0.91
Deletion of mtrC in Haemophilus ducreyi increases sensitivity to human antimicrobial peptides and activates the CpxRA regulon. Infect Immun (2011) 0.90
Immune regulation during chronic visceral leishmaniasis. PLoS Negl Trop Dis (2014) 0.88
Interaction of Plasmodium falciparum histidine-rich protein II with human lymphocytes leads to suppression of proliferation, IFN-gamma release, and CD69 expression. Parasitol Res (2006) 0.87
The Regulation of CD4(+) T Cell Responses during Protozoan Infections. Front Immunol (2014) 0.85
HLA class II polymorphisms and susceptibility to recurrent respiratory papillomatosis. J Virol (2003) 0.85
CD19(+) B cells confer protection against experimental cerebral malaria in semi-immune rodent model. PLoS One (2013) 0.81
Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide. Immunology (2006) 0.81
The malaria candidate vaccine liver stage antigen-3 is highly conserved in Plasmodium falciparum isolates from diverse geographical areas. Malar J (2009) 0.78
Mannan-mediated gene delivery for cancer immunotherapy. Immunology (2007) 0.78
Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines. Malar J (2005) 0.78
The effect of declining exposure on T cell-mediated immunity to Plasmodium falciparum - an epidemiological "natural experiment". BMC Med (2016) 0.76
Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection. Cell Rep (2016) 0.76
A CD4+ T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function. Retrovirology (2014) 0.75
Vaccination with Altered Peptide Ligands of a Plasmodium berghei Circumsporozoite Protein CD8 T-Cell Epitope: A Model to Generate T Cells Resistant to Immune Interference by Polymorphic Epitopes. Front Immunol (2017) 0.75
Malaria Parasites: The Great Escape. Front Immunol (2016) 0.75
The nature of the isometric twitch. J Physiol (1921) 30.00
A new mathematical treatment of changes of ionic concentration in muscle and nerve under the action of electric currents, with a theory as to their mode of excitation. J Physiol (1910) 23.56
The heat-production in prolonged contractions of an isolated frog's muscle. J Physiol (1913) 23.23
The regulation of the supply of energy in muscular contraction. J Physiol (1921) 22.57
Length of muscle, and the heat and tension developed in an isometric contraction. J Physiol (1925) 19.20
The recovery heat-production in muscle. J Physiol (1922) 19.13
The four phases of heat-production of muscle. J Physiol (1920) 18.40
Repetitive stimulation by commutator and condenser. J Physiol (1934) 15.17
The absolute mechanical efficiency of the contraction of an isolated muscle. J Physiol (1913) 14.19
Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet (1997) 13.64
The relation of length to tension development and heat production on contraction in muscle. J Physiol (1914) 11.40
The anaerobic processes involved in muscular activity. J Physiol (1923) 11.31
The nature of oxyhaemoglobin, with a note on its molecular weight. J Physiol (1910) 10.05
A new form of differential micro-calorimeter, for the estimation of heat production in physiological, bacteriological, or ferment actions. J Physiol (1911) 8.14
The effect of frequency of excitation on the total electric response of medullated nerve. J Physiol (1935) 7.58
The effect of hydrogen-ion concentration on the recovery process in muscle. J Physiol (1924) 7.30
Rapid effector function in CD8+ memory T cells. J Exp Med (1997) 6.36
TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet (1990) 6.32
Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med (1998) 6.14
The effect of frequency of stimulation on the heat production of nerve. J Physiol (1927) 6.06
On the hydrogen-ion concentration and some related properties of normal human blood. J Physiol (1922) 5.20
Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med (2001) 5.06
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet (2001) 5.01
Evolutionary relationships of human populations from an analysis of nuclear DNA polymorphisms. Nature (1986) 4.84
The mode of action of nicotine and curari, determined by the form of the contraction curve and the method of temperature coefficients. J Physiol (1909) 4.81
Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet (1990) 4.58
The maximum work and mechanical efficiency of human muscles, and their most economical speed. J Physiol (1922) 4.39
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature (1994) 4.37
The heat production of muscles treated with caffein or subjected to prolonged discontinuous stimulation. J Physiol (1924) 4.33
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med (1998) 4.13
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol Biochem Parasitol (2000) 4.08
Oral cimetidine in severe duodenal ulceration. A double-blind controlled trial. Lancet (1977) 3.95
Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol (2001) 3.79
Electric excitation of the fin nerve of sepia. J Physiol (1935) 3.76
Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1998) 3.59
Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis (2000) 3.58
Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med (1995) 3.54
Association of malaria parasite population structure, HLA, and immunological antagonism. Science (1998) 3.40
Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis (2001) 3.36
Effect of season and temperature on mortality in amphibians due to chytridiomycosis. Aust Vet J (2004) 3.16
Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet (2001) 3.15
In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med (2000) 3.04
Acute lower respiratory tract infections in children: possible criteria for selection of patients for antibiotic therapy and hospital admission. Bull World Health Organ (1984) 2.97
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet (1999) 2.83
Genetics of susceptibility to human infectious disease. Nat Rev Genet (2001) 2.80
Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis (1999) 2.79
mtDNA control-region sequence variation suggests multiple independent origins of an "Asian-specific" 9-bp deletion in sub-Saharan Africans. Am J Hum Genet (1996) 2.79
Prophylactic oral antimicrobial agents in elective colonic surgery. A controlled trial. Lancet (1975) 2.72
Changes in house design reduce exposure to malaria mosquitoes. Trop Med Int Health (2003) 2.71
High frequencies of alpha-thalassaemia are the result of natural selection by malaria. Nature (1986) 2.68
Comparison of a parasite lactate dehydrogenase-based immunochromatographic antigen detection assay (OptiMAL) with microscopy for the detection of malaria parasites in human blood samples. Am J Trop Med Hyg (1999) 2.57
The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy. Trans R Soc Trop Med Hyg (2001) 2.54
Do untreated bednets protect against malaria? Trans R Soc Trop Med Hyg (2001) 2.50
Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci U S A (2000) 2.44
The Specific Electrical Resistance of Frog's Muscle. Biochem J (1921) 2.44
Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis. Infect Immun (2001) 2.31
Direct cloning of specific genomic DNA sequences in plasmid libraries following fragment enrichment. Nucleic Acids Res (1985) 2.27
Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J (2010) 2.27
Analysis of the human alpha-globin gene cluster reveals a highly informative genetic locus. Proc Natl Acad Sci U S A (1986) 2.26
Vaccines against intracellular infections requiring cellular immunity. Nature (2000) 2.20
Long term cimetidine in the management of severe duodenal ulcer dyspepsia. Gastroenterology (1978) 2.15
The heat-production and the mechanism of the veratrine contraction. J Physiol (1922) 2.11
High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet (1992) 2.09
Malaria susceptibility and CD36 mutation. Nature (2000) 2.07
High viral burden in the presence of major HIV-specific CD8(+) T cell expansions: evidence for impaired CTL effector function. Eur J Immunol (2001) 1.99
1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun (1998) 1.96
Retroperitoneal necrotizing fasciitis. Br J Surg (1992) 1.90
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet (2000) 1.90
Adult intussusception in Glasgow. Br J Surg (1968) 1.88
The pressure developed in muscle during contraction. J Physiol (1948) 1.81
Strong HLA class I--restricted T cell responses in dengue hemorrhagic fever: a double-edged sword? J Infect Dis (2001) 1.79
Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. J Infect Dis (1999) 1.76
The analysis of galvanometer curves. J Physiol (1930) 1.76
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine (1998) 1.74
Endoscopic sphincterotomy for bile duct stones in patients with intact gallbladders. Br J Surg (1989) 1.73
Induction of CD8+ T cells using heterologous prime-boost immunisation strategies. Immunol Rev (1999) 1.72
A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. Am J Trop Med Hyg (1998) 1.72
Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet (1997) 1.71
Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds. Infect Immun (1997) 1.71
The long term stability of the insulin test. Gastroenterology (1970) 1.69
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. J Infect Dis (1998) 1.66
An empirical exploration of the (delta mu)2 genetic distance for 213 human microsatellite markers. Am J Hum Genet (1999) 1.66
The heat-producton of surviving amphibian muscles, during rest, activity, and rigor. J Physiol (1912) 1.65
A protein particle vaccine containing multiple malaria epitopes. Nat Biotechnol (1997) 1.61
The energy degraded in the recovery processes of stimulated muscles. J Physiol (1913) 1.60
Alcohol sales to underage adolescents: an unobtrusive observational field study and evaluation of a police intervention. Addiction (2000) 1.58
Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J Immunol (2000) 1.58
Melanesians and Polynesians share a unique alpha-thalassemia mutation. Am J Hum Genet (1985) 1.58
Parasite virulence and disease patterns in Plasmodium falciparum malaria. Proc Natl Acad Sci U S A (1994) 1.57
Independent recombination events between the duplicated human alpha globin genes; implications for their concerted evolution. Nucleic Acids Res (1984) 1.54
Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis (1999) 1.54
Linkage disequilibrium between two chromosomally distinct loci associated with increased resistance to chloroquine in Plasmodium falciparum. Parasitology (2000) 1.51
Methods for derivation and detection of anti-parasite monoclonal antibodies. J Immunol Methods (1980) 1.49
Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic. Sex Transm Infect (2002) 1.49
Epidemiological aspects of Crohn's disease in Clydesdale 1961-1970. Gut (1975) 1.49
A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat Genet (2001) 1.48